Progress of the pathogenic factors and treatment of fetal spina bifida

doi:10.3877/cma.j.issn.2095-9141.2021.03.012

Abstract

Abstract:

With the development of imaging, the detection rate of prenatal fetal nervous system abnormalities is increasing, and spina bifida is also continuously detected. However, there is currently no unified answer to the question of whether pregnancy should be terminated after fetal spina bifida is found. The literature reports on the pathogenic factors and treatment-related progress of fetal spina bifida are scattered. This article mainly focuses on the pathogenic factors of fetal spina bifida, treatment-related progress, and whether to terminate pregnancy and other issues, and proposes corresponding diagnosis and treatment strategies in order to provide reference for clinical treatment.

Key words: Spina bifida, Neural stem cell, Prenatal fetal

Yong Yu, Hua Yang, Kaya Xu. Progress of the pathogenic factors and treatment of fetal spina bifida[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2021, 07(03): 187-190.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsjcswkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9141.2021.03.012

https://zhsjcswkdzzz.cma-cmc.com.cn/EN/Y2021/V07/I03/187

References 41

[1]	Copp AJ, Adzick NS, Chitty LS, et al. Spina bifida[J]. Nat Rev Dis Primers, 2015, 1: 15007.
[2]	Adzick NS. Fetal myelomeningocele: natural history, pathophysiology, and in-utero intervention[J]. Semin Fetal Neonatal Med, 2010, 15(1): 9-14.
[3]	Li Z, Ren A, Zhang L. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China[J]. Birth Defects Res A Clin Mol Teratol, 2006, 76(4): 237-240.
[4]	Sahmat A, Gunasekaran R, Mohd-Zin SW, et al. The prevalence and distribution of spina bifida in a single major referral center in Malaysia[J]. Front Pediatr, 2017, 55: 237.
[5]	Beyer DA, Diedrich K, Weichert J, et al. Seasonality of spina bifida in northern Germany[J]. Arch Gynecol Obstet, 2011, 284(4): 849-854.
[6]	Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001[J]. Birth Defects Res A Clin Mol Teratol, 2006, 76(11): 747-756.
[7]	Fauza DO, Jennings RW, Teng YD, et al. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida[J]. Surgery, 2008, 144(3): 367-373.
[8]	王维.叶酸的绿色合成工艺研究[D].南京:东南大学, 2016.
[9]	Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects[J]. Am J Med Genet C Semin Med Genet, 2005, 135C(1): 9-23.
[10]	Zhang T, Lou J, Zhong R, et al. Genetic variants in the folate pathway and the risk of neural tube defects: a meta-analysis of the published literature[J]. PLoS One, 2013, 8(4): e59570.
[11]	Mohd-Zin SW, Marwan AI, Abou C, et al. Spina bifida: pathogenesis, mechanisms, and genes in mice and humans[J]. Scientifica, 2017, 2017: 5364827.
[12]	Atta CA, Fiest KM, Frolkis AD, et al. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis[J]. Am J Public Health, 2016, 106(1): e24-e34.
[13]	Blomberg MI, Källén B. Maternal obesity and morbid obesity: the risk for birth defects in the offspring[J]. Birth Defects Res A Clin Mol Teratol, 2010, 88(1): 35-40.
[14]	Carmichael SL, Rasmussen SA, Shaw GM. Prepregnancy obesity: a complex risk factor for selected birth defects[J]. Birth Defects Res A Clin Mol Teratol, 2010, 88(10): 804-810.
[15]	Stothard KJ, Tennant PWG, Bell R, et al. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis[J]. JAMA, 2009, 301(6): 636-650.
[16]	Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women[J]. Trends Endocrinol Metab, 2001, 12(2): 78-82.
[17]	Davidson CM, Northrup H, King TM, et al. Genes in glucose metabolism and association with spina bifida[J]. Reprod Sci, 2008, 15(1): 51-58.
[18]	Murdoch JN, Damrau C, Paudyal A, et al. Genetic interactions between planar cell polarity genes cause diverse neural tube defects in mice[J]. Dis Model Mech, 2014, 7(10): 1153-1163.
[19]	Keller R. Shaping the vertebrate body plan by polarized embryonic cell movements[J]. Science, 2002, 298(5600): 1950-1954.
[20]	Goodrich LV, Strutt D. Principles of planar polarity in animal development[J]. Development, 2011, 138(10): 1877-1892.
[21]	Veeman MT, Slusarski DC, Kaykas A, et al. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements[J]. Curr Biol, 2003, 13(8): 680-685.
[22]	Tada M, Smith JC. Xwnt11 is a target of xenopus brachyury: regulation of gastrulation movements via dishevelled, but not through the canonical Wnt pathway[J]. Development, 2000, 127(10): 2227-2238.
[23]	Allache R, De Marco P, Merello E, et al. Role of the planar cell polarity gene CELSR1 in neural tube defects and caudal agenesis[J]. Birth Defects Res A Clin Mol Teratol, 2012, 94(3): 176-181.
[24]	Greene ND, Stanier P, Copp AJ. Genetics of human neural tube defects[J]. Hum Mol Genet, 2009, 18(R2): R113-R129.
[25]	Harris MJ. Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants[J]. Birth Defects Res A Clin Mol Teratol, 2009, 85(4): 331-339.
[26]	Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects[J]. Dev Disabil Res Rev, 2010, 16(1): 6-15.
[27]	Radbruch A, Isaacs J. Animal models in infection and inflammation-chance and necessity[J]. Eur J Immunol, 2010, 39(8): 1991-1993.
[28]	Meuli M, Meuli-Simmen C, Yingling CD, et al. Creation of myelomeningocele in utero: a model of functional damage from spinal cord exposure in fetal sheep[J]. J Pediatr Surg, 1995, 30(7): 1028-1032.
[29]	Meuli M, Meuli-Simmen C, Hutchins GM, et al. In utero surgery rescues neurological function at birth in sheep with spina bifida[J]. Nature Medicine, 1995, 1(4): 342-347.
[30]	Adzick NS. Fetal surgery for spina bifida: past, present, future[J]. Semin Pediatr Surg, 2013, 22(1): 10-17.
[31]	Adzick NS. Fetal surgery for myelomeningocele: trials and tribulations. Isabella Forshall Lecture[J]. J Pediatr Surg, 2012, 47(2): 273-281.
[32]	Inversetti A, Van der Veeken L, Thompson D, et al. Neurodevelopmental outcome of children with spina bifida aperta repaired prenatally vs postnatally: systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2019, 53(3): 293-301.
[33]	Papanna R, Moise KJ Jr, Mann LK, et al. Cryopreserved human umbilical cord patch for in-utero spina bifida repair[J]. Ultrasound Obstet Gynecol, 2016, 47(2): 168-176.
[34]	Mann LK, Won JH, Trenton NJ, et al. Cryopreserved human umbilical cord versus acellular dermal matrix patches for in utero fetal spina bifida repair in a pregnant rat model[J]. J Neurosurg Spine, 2019, 32(2): 321-331.
[35]	Sacco A, Van der Veeken L, Bagshaw E, et al. Maternal complications following open and fetoscopic fetal surgery: a systematic review and meta-analysis[J]. Prenat Diagn, 2019, 39(4): 251-268.
[36]	Pedreira DA, Reece EA, Chmait RH, et al. Fetoscopic repair of spina bifida: safer and better?[J]. Ultrasound Obstet Gynecol, 2016, 48(2): 141-147.
[37]	Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details[J]. Cell Stem Cell, 2009, 4(3): 206-216.
[38]	Prockop DJ, Kota DJ, Bazhanov N, et al. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs)[J]. J Cell Mol Med, 2010, 14(9): 2190-2199.
[39]	Li H, Gao F, Ma L, et al. Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta[J]. J Cell Mol Med, 2012, 16(7): 1606-1617.
[40]	Bamba Y, Nonaka M, Sasaki N, et al. Generation of induced pluripotent stem cells and neural stem/progenitor cells from newborns with spina bifida aperta[J]. Asian Spine J, 2017, 11(6): 870-879.
[41]	Okano H, Nakamura M, Yoshida K, et al. Steps toward safe cell therapy using induced pluripotent stem cells[J]. Circ Res, 2013, 112(3): 523-533.

Please choose a citation manager

Content to export